Hansoh Pharmaceutical Group Company Limited (03692.HK)
03692.HK Stock Price Chart
HANSOH PHARMA (03692.HK)
Hansoh Pharmaceutical Group Company Limited
HK$35.16
-1.51%
$-0.54
CLOSED_MARKET: May 15, 16:00:00 HKT
Key Stats
Prev.Close
$35.7
Open
$35.7
Day's Range
$34.78 - $35.74
52 week range
$23.1 - $44.22
Volume
9.5M
Avg.Volume
9.5M
Dividend yield
--
EPS (TTM)
1.06
Market Cap
$212.6B
What is HANSOH PHARMA?
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.